Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.840
-0.220 (-10.68%)
Dec 5, 2025, 4:00 PM EST - Market closed
Artelo Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 |
| Market Capitalization | 4 | 3 | 4 | 8 | 22 | 22 | |
| Market Cap Growth | -4.76% | -23.37% | -45.90% | -62.41% | -1.60% | 416.89% | |
| Enterprise Value | 3 | -1 | -8 | -11 | 12 | 12 | |
| Last Close Price | 1.84 | 6.36 | 8.40 | 17.34 | 46.71 | 81.98 | |
| PB Ratio | - | 1.20 | 0.38 | 0.43 | 0.81 | 1.85 | |
| P/TBV Ratio | - | 4.18 | 0.46 | 0.48 | 0.87 | 2.23 | |
| Debt / Equity Ratio | -1.51 | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Quick Ratio | 0.35 | 1.32 | 8.08 | 17.57 | 23.48 | 19.14 | |
| Current Ratio | 0.38 | 1.44 | 8.51 | 18.36 | 23.96 | 19.61 | |
| Return on Equity (ROE) | -436.14% | -134.52% | -59.63% | -43.30% | - | -93.45% | |
| Return on Assets (ROA) | -136.26% | -71.22% | -37.09% | -26.42% | - | -54.68% | |
| Return on Capital (ROIC) | -228.69% | -85.74% | -39.73% | -27.52% | - | -58.09% | |
| Return on Capital Employed (ROCE) | 2096.10% | -345.50% | -84.50% | -53.00% | -44.50% | -61.50% | |
| Earnings Yield | -336.28% | -287.20% | -208.06% | -122.17% | -55.14% | -33.33% | |
| FCF Yield | -220.11% | -244.06% | -183.83% | -97.03% | -36.44% | -27.52% | |
| Buyback Yield / Dilution | -23.24% | -8.88% | -4.48% | -27.04% | -79.12% | -403.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.